Hana Pharm Co Ltd
KRX:293480
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
KR |
|
Bank of The James Financial Group, Inc
NASDAQ:BOTJ
|
US |
|
Humana Inc
NYSE:HUM
|
US |
Intrinsic Value
The intrinsic value of Hana Pharm Co Ltd (293480) under the Base Case is 8 473.28 KRW per share. Compared with the current market price of 8 210 KRW, the stock appears Undervalued by 3% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Hana Pharm Does
Hana Pharm is a South Korean drugmaker that develops, manufactures, and sells medicines for human use. Its main business is making prescription drugs and other pharmaceutical products that are sold through hospitals, clinics, pharmacies, and medical wholesalers. The company’s work sits in the middle of the healthcare supply chain: it turns drug formulas into finished medicines that doctors and pharmacists can give to patients.
- Headquarters
- Korea KR
- Employees
- 657
- IPO date
- Oct 2, 2018
Revenue & Expenses Breakdown
Hana Pharm Co Ltd
Earnings Waterfall
Hana Pharm Co Ltd
The intrinsic value for Hana Pharm Co Ltd (293480) under the Base Case is 8 473.28 KRW.
Compared with the current market price of 8 210 KRW, the stock appears Undervalued by 3% .